SCHEMBL6306186

SCHEMBL6306186

CC(C)(C)OC(=O)CC(=O)N(CC(F)(F)F)c1ccc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MT-CO2 P00403 1/20 0.37
GAA P10253 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CYP3A4 P08684 1/20 0.35
CNR2 P34972 1/20 0.35
RORC P51449 1/20 0.34
MMP2 P08253 1/20 0.34
MMP9 P14780 1/20 0.34
NR1D1 P20393 1/20 0.34
NR1H3 Q13133 1/20 0.34
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20671836 0.79 CYP3A4 (0.44) GAANPSR1KDM4EALDH1A1POLB
SCHEMBL20672082 0.75 NPSR1 (0.38) GAANPSR1KDM4EALDH1A1POLB
SCHEMBL10893930 0.74 RORC (0.46) GAANPSR1ALDH1A1MAPTHSD17B10
SCHEMBL20195140 0.72 RAB9A (0.40) KDM4EALDH1A1POLBMAPTCNR2
SCHEMBL6515670 0.72 ALDH1A1 (0.52) GAANPSR1KDM4EALDH1A1MAPT
SCHEMBL20183678 0.71 MAPT (0.38) KDM4EALDH1A1POLBMAPTMEN1
SCHEMBL25213314 0.70 CYP3A4 (0.43) MT-CO2ALDH1A1MAPTCYP3A4CNR2
SCHEMBL3959237 0.70 RORC (0.37) MT-CO2KDM4EALDH1A1POLBMAPT
SCHEMBL9859381 0.69 ERCC5 (0.51) GAAKDM4EALDH1A1POLBMAPT
SCHEMBL3657533 0.68 MT-CO2 (0.46) MT-CO2GAANPSR1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921821-B2 Antagonists of melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2005-07-26 US disclosed
US-20040106645-A1 Antagonists of melanin concentrating hormone receptor MILLENNIUM PHARMACEUTICALS, INC. 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106645-A1 Antagonists of melanin concentrating hormone receptor MCHR1, MCHR2, MC1R MT-CO2 237/4885GAA 1067/4885NPSR1 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.